ALX Oncology Announces November Investor Conference Participation
ALX Oncology (Nasdaq: ALXO) announced its participation in two upcoming investor conferences in November 2024. The company will participate in the UBS Global Healthcare Conference on November 12 at 3:30 PM PST in Rancho Palos Verdes, CA, featuring a fireside chat with analyst Trung Huynh. Additionally, they will attend the Jefferies London Healthcare Conference on November 19 at 9:00 AM GMT in London, with analyst Michael Yee. Both events will include 1x1 meetings and webcasts accessible through ALX Oncology's website, with replays available for up to 90 days.
ALX Oncology (Nasdaq: ALXO) ha annunciato la sua partecipazione a due prossime conferenze per investitori nel novembre 2024. L'azienda parteciperà al UBS Global Healthcare Conference il 12 novembre alle 15:30 PST a Rancho Palos Verdes, CA, con una chiacchierata informale con l'analista Trung Huynh. Inoltre, parteciperanno al Jefferies London Healthcare Conference il 19 novembre alle 9:00 AM GMT a Londra, con l'analista Michael Yee. Entrambi gli eventi includeranno incontri 1x1 e webcast accessibili tramite il sito web di ALX Oncology, con registrazioni disponibili per un massimo di 90 giorni.
ALX Oncology (Nasdaq: ALXO) anunció su participación en dos próximas conferencias para inversores en noviembre de 2024. La empresa participará en la UBS Global Healthcare Conference el 12 de noviembre a las 3:30 PM PST en Rancho Palos Verdes, CA, con una charla junto al fuego con el analista Trung Huynh. Además, asistirán a la Jefferies London Healthcare Conference el 19 de noviembre a las 9:00 AM GMT en Londres, con el analista Michael Yee. Ambos eventos incluirán reuniones 1x1 y transmisiones web accesibles a través del sitio web de ALX Oncology, con repeticiones disponibles durante un máximo de 90 días.
ALX Oncology (Nasdaq: ALXO)는 2024년 11월에 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 11월 12일 오후 3시 30분 PST에 캘리포니아주 랜초 팔로스 베르데스에서 열리는 UBS Global Healthcare Conference에 참가하며, 분석가 Trung Huynh와 함께하는 간담회를 진행합니다. 또한 11월 19일 오전 9시 GMT에 런던에서 열리는 Jefferies London Healthcare Conference에도 참석하며, 분석가 Michael Yee와 함께합니다. 두 이벤트 모두 1:1 미팅과 ALX Oncology 웹사이트를 통해 접근할 수 있는 웹캐스트를 포함하며, 재생은 최대 90일 동안 가능합니다.
ALX Oncology (Nasdaq: ALXO) a annoncé sa participation à deux prochaines conférences pour investisseurs en novembre 2024. L'entreprise participera à la UBS Global Healthcare Conference le 12 novembre à 15h30 PST à Rancho Palos Verdes, CA, avec une discussion informelle avec l'analyste Trung Huynh. De plus, ils assisteront à la Jefferies London Healthcare Conference le 19 novembre à 9h00 GMT à Londres, avec l'analyste Michael Yee. Les deux événements comprendront des réunions individuelles et des webdiffusions accessibles via le site web d'ALX Oncology, avec des rediffusions disponibles jusqu'à 90 jours.
ALX Oncology (Nasdaq: ALXO) gab die Teilnahme an zwei bevorstehenden Investorenkonferenzen im November 2024 bekannt. Das Unternehmen wird am 12. November um 15:30 Uhr PST an der UBS Global Healthcare Conference in Rancho Palos Verdes, Kalifornien, teilnehmen, wo eine Gesprächsrunde mit dem Analysten Trung Huynh stattfinden wird. Darüber hinaus werden sie am 19. November um 9:00 Uhr GMT in London an der Jefferies London Healthcare Conference teilnehmen, mit dem Analysten Michael Yee. Beide Veranstaltungen umfassen 1x1-Meetings und Webcasts, die über die Website von ALX Oncology zugänglich sind, mit Aufzeichnungen, die bis zu 90 Tage verfügbar sind.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives, today announced that management will participate in two upcoming investor conferences.
2024 UBS Global Healthcare Conference
Format: Fireside chat with analyst, Trung Huynh, and 1x1 meetings
Date: Tuesday, November 12
Time: 3:30 PM PST
Location: Rancho Palos Verdes, CA
Webcast link: Available here
2024 Jefferies London Healthcare Conference
Format: Fireside chat with analyst, Michael Yee, and 1x1 meetings
Date: Tuesday, November 19
Time: 9:00 AM GMT
Location: London, UK
Webcast link: Available here
The live webcasts for the UBS and Jefferies fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com and selecting Events under the News and Events tab. A replay of the webcast will be archived for up to 90 days following the fireside chat date.
About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer in new ways and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology.
FAQ
When is ALX Oncology (ALXO) presenting at the UBS Global Healthcare Conference 2024?
When is ALX Oncology (ALXO) presenting at the Jefferies London Healthcare Conference 2024?
How long will ALX Oncology's (ALXO) conference webcasts be available for replay?
